multicent trial l-carnitin mainten hemodialysi patient carnitin concentr lipid effect previou studi conflict result carnitin supplement plasma lipid patient chronic renal failur center double-blind placebo trial effect post-hemodialysi intraven inject l-carnitin esrd patient mainten hemodialysi thirty-eight patient month l-carnitin infus mg/kg post-dialysi patient placebo infus group patient baselin pre-dialysi plasma red blood cell total carnitin level normal pre-dialysi plasma-fre carnitin concentr free/tot ratio subnorm acyl level post-dialysi plasma free total carnitin concentr subnorm plasma red blood cell total carnitin level carnitin recipi unchang baselin placebo signific chang plasma triglycerid hdl-cholesterol lipoprotein paramet carnitin placebo group carnitin metabol uremia furthermor randomly-select hemodialysi popul l-carnitin inject dose mg/kg result signific increas blood tissu carnitin level major effect lipid profil 